Baker Heart and Diabetes Institute
41
8
9
14
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
17.1%
7 terminated/withdrawn out of 41 trials
66.7%
-19.8% vs industry average
37%
15 trials in Phase 3/4
14%
2 of 14 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (41)
The STOP-MED CTRCD Trial
Role: collaborator
Effects of Lentil Protein Hydrolysate on Blood Pressure Control, Vascular Function and Exercise Performance
Role: collaborator
Risk-guided Disease managEment Plan to prevEnt CAD in Patients Treated With Previous Cancer
Role: lead
Evaluating Safe Ketone Thresholds To Minimise Ketosis in People With Type 1 Diabetes Using Dapagliflozin
Role: collaborator
Use of Artificial Intelligence-Guided Echocardiography to assIst cardiovascuLar Patient managEment
Role: lead
Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)
Role: lead
Risk-guided Disease Management in Coronary Artery Disease
Role: lead
Exercise to Improve Neurovascular Function in Breast Cancer Survivors
Role: lead
The Mauritius and Rodrigues Non-Communicable Disease (NCD) Study
Role: collaborator
Risk-guided Disease Management Plan to Prevent Heart Failure in Patients Treated With Previous Chemotherapy (REDEEM)
Role: lead
Real-World Evaluation of a Digitally Enabled Cardiac Rehabilitation Program
Role: lead
Echo Acquisition Despite Geographic Separation by Replication of Human Movements (EAGER)
Role: lead
Early Detection of Coronary Artery Disease by Polygenic and Metabolic Risk Scoring
Role: lead
Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor
Role: lead
Major Depressive Disorder - Understanding The Link Between The Brain And The Heart
Role: lead
Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney Disease
Role: lead
Sham Controlled Clinical Trial of Renal Denervation in Patients With Resistant Hypertension
Role: lead
Renal Denervation to Improve Outcomes in Patients With End-stage Renal Disease
Role: lead
Effect of Ghrelin on Sympathetic Nervous System
Role: lead
Effects of Detraining in Endurance Athletes With Atrial Fibrillation
Role: collaborator